StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) PT Lowered to $317 at RBC Capital
April 25, 2024 6:39 AM
RBC Capital analyst Brian Abrahams lowered the price target on Biogen (NASDAQ: BIIB) to $317.00 (from $326.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Biogen (BIIB) PT Lowered to $340 at Goldman Sachs
April 25, 2024 6:21 AM
Biogen (BIIB) PT Lowered to $340 at Goldman Sachs
April 25, 2024 6:20 AM
Biogen (BIIB) PT Lowered to $200 at Barclays
April 25, 2024 3:31 AM
Form 10-Q BIOGEN INC. For: Mar 31
April 24, 2024 4:16 PM
Biogen (BIIB) PT Raised to $215 at Wedbush
April 24, 2024 4:06 PM
JPMorgan First Take on Biogen (BIIB)
April 24, 2024 9:06 AM
BMO Capital First Take on Biogen (BIIB) Earnings
April 24, 2024 7:57 AM
Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
April 24, 2024 7:43 AM
Form 8-K BIOGEN INC. For: Apr 24
April 24, 2024 7:03 AM
Biogen (BIIB) tops earnings expectations but revenue falls short
April 24, 2024 7:02 AM
Biogen cost cuts drive profit beat, as Alzheimer's drug off to slow start
April 24, 2024 6:48 AM
Biogen (BIIB) Tops Q1 EPS by 24c; reaffirms guidance
April 24, 2024 6:46 AM
